James E Carter
Overview
Explore the profile of James E Carter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
594
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Milliken W, Brown W, Carter J, Marrett J, Sweat L, Davis G, et al.
Halls J Health
. 2022 Dec;
21(12):479.
PMID: 36487795
No abstract available.
2.
Tyagi N, Deshmukh S, Srivastava S, Azim S, Ahmad A, Al-Ghadhban A, et al.
Mol Cancer Res
. 2017 Nov;
16(2):187-196.
PMID: 29117940
The ETS family transcription factor ETV4 is aberrantly expressed in a variety of human tumors and plays an important role in carcinogenesis through upregulation of relevant target gene expression. Here,...
3.
Deshmukh S, Srivastava S, Tyagi N, Ahmad A, Singh A, Ghadhban A, et al.
Carcinogenesis
. 2017 Apr;
38(8):757-765.
PMID: 28430867
Although increased awareness leading to early detection and prevention, as well as advancements in treatment strategies, have resulted in superior clinical outcomes, African American women with breast cancer continue to...
4.
Deshmukh S, Srivastava S, Zubair H, Bhardwaj A, Tyagi N, Al-Ghadhban A, et al.
Cancer Lett
. 2017 Mar;
396:21-29.
PMID: 28302531
Breast cancer (BC) continues to be the most frequently diagnosed cancer in American women, which disproportionately affects women of African-American (AA) descent. Previously, we reported greater serum levels of resistin...
5.
Ahmad A, Azim S, Zubair H, Khan M, Singh S, Carter J, et al.
Biochim Biophys Acta Rev Cancer
. 2017 Jan;
1868(1):16-28.
PMID: 28108348
Despite efforts at various levels, racial health disparities still exist in cancer patients. These inequalities in incidence and/or clinical outcome can only be explained by a multitude of factors, with...
6.
Bhardwaj A, Srivastava S, Khan M, Prajapati V, Singh S, Carter J, et al.
Front Biosci (Landmark Ed)
. 2016 Nov;
22(5):772-782.
PMID: 27814645
Prostate cancer incidence and mortality rates are remarkably higher in African-American men as compared to their European-Americans counterparts. Despite these recognitions, precise causes underlying such prevalent racial disparities remain poorly...
7.
Tyagi N, Srivastava S, Arora S, Omar Y, Ijaz Z, Al-Ghadhban A, et al.
Cancer Lett
. 2016 Oct;
383(1):53-61.
PMID: 27693632
Sunscreen formulations containing UVB filters, such as Zinc-oxide (ZnO) and titanium-dioxide (TiO) nanoparticles (NPs) have been developed to limit the exposure of human skin to UV-radiations. Unfortunately, these UVB protective...
8.
Averett C, Bhardwaj A, Arora S, Srivastava S, Khan M, Ahmad A, et al.
Carcinogenesis
. 2016 Sep;
37(11):1052-1061.
PMID: 27609457
The poor clinical outcome of pancreatic cancer (PC) is largely attributed to its aggressive nature and refractoriness to currently available therapeutic modalities. We previously reported antitumor efficacy of honokiol (HNK),...
9.
Bhardwaj A, Srivastava S, Singh S, Tyagi N, Arora S, Carter J, et al.
J Biol Chem
. 2016 Jun;
291(31):16263-70.
PMID: 27246849
Extensive desmoplasia is a prominent pathological characteristic of pancreatic cancer (PC) that not only impacts tumor development, but therapeutic outcome as well. Recently, we demonstrated a novel role of MYB,...
10.
Srivastava S, Bhardwaj A, Arora S, Singh S, Azim S, Tyagi N, et al.
Br J Cancer
. 2015 Dec;
113(12):1694-703.
PMID: 26657649
Background: MYB encodes for a transcription factor regulating the expression of a wide array of genes involved in cellular functions. It is reported to be amplified in a sub-set of...